These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 19339208
21. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy. Shlamkovich T, Aharon L, Barton WA, Papo N. Oncotarget; 2017 May 16; 8(20):33571-33585. PubMed ID: 28422724 [Abstract] [Full Text] [Related]
24. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy. Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP. Transplant Proc; 2008 Oct 16; 40(8):2795-9. PubMed ID: 18929864 [Abstract] [Full Text] [Related]
30. Regulation of tie2 expression by angiopoietin--potential feedback system. Hashimoto T, Wu Y, Boudreau N, Li J, Matsumoto M, Young W. Endothelium; 2004 Apr 30; 11(3-4):207-10. PubMed ID: 15370298 [Abstract] [Full Text] [Related]
33. Enhanced expression of angiopoietin-2 and the Tie2 receptor but not angiopoietin-1 or the Tie1 receptor in a rat model of myocardial infarction. Shyu KG, Liang YJ, Chang H, Wang BW, Leu JG, Kuan P. J Biomed Sci; 2004 Apr 30; 11(2):163-71. PubMed ID: 14966366 [Abstract] [Full Text] [Related]
34. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Findley CM, Cudmore MJ, Ahmed A, Kontos CD. Arterioscler Thromb Vasc Biol; 2007 Dec 30; 27(12):2619-26. PubMed ID: 17901375 [Abstract] [Full Text] [Related]
35. Autocrine/paracrine role of the angiopoietin-1 and -2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis. Takahara K, Iioka T, Furukawa K, Uchida T, Nakashima M, Tsukazaki T, Shindo H. Hum Pathol; 2004 Feb 30; 35(2):150-8. PubMed ID: 14991531 [Abstract] [Full Text] [Related]
36. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH, Minchinton AI, Yancopoulos GD, Thurston G. Cancer Res; 2013 Jan 01; 73(1):108-18. PubMed ID: 23149917 [Abstract] [Full Text] [Related]